10x Growth,11x Earnings

Sales have climbed from $43 Million to $860 Million in just two years.

Highlights:

• This medical company sells a best-selling imaging agent for the identification of cancer cells.

• Profits have risen tenfold in just two years. Yet the stock trades at only 11x earnings.

• Investors are focussed on fears of competition. But they may be overlooking the company’s first-mover advantage and unique strengths.